[The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
作者信息
Morselli P L, Rizzo M, Tognoni G
出版信息
Recenti Prog Med. 1970 Feb;48(2):97-124.
PMID:5467589
Abstract
摘要
相似文献
1
[The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
Recenti Prog Med. 1970 Feb;48(2):97-124.
2
[L-Dopa in Parkinson's-syndrome. New therapeutic attack?].
Ther Ggw. 1970 Nov;109(11):1590-3.
3
L-dopa in Parkinson's syndrome.
N Engl J Med. 1969 Feb 13;280(7):382-3. doi: 10.1056/NEJM196902132800708.
4
[10 years of L-DOPA therapy of Parkinson's syndrome].
Wien Klin Wochenschr. 1971 Apr 2;83(13):221-7.
5
L-dopa metabolism in man (with special reference to parkinsonism).
Sci Basis Med Annu Rev. 1972:161-73.
6
[Biochemical and clinical correlations in Parkinson's disease].
Rev Neurol (Paris). 1972 Aug;127(2):253-64.
7
[Treatment of Parkinson's disease with L-dopa].
Clin Ter. 1970 May 15;53(3):259-69.
8
Cerebral catecholamine concentration after L-dopa therapy in Parkinson's disease.
Trans Am Neurol Assoc. 1970;95:247-8.
9
Dopaminergic nervous transmission in Parkinson's disease.
Med Biol. 1974 Jun;52(3):208-17.
10
L-dopa, behavioral activation and psychopathology.
Res Publ Assoc Res Nerv Ment Dis. 1972;50:472-93.
Zotero 插件